Hippo DX is a MedTech start-up introducing a state-of-the-art medical device, S.P.A.T. (Skin Prick Automated Test) for automated allergy testing. The S.P.A.T. device executes 12 equal pricks simultaneously in 20 seconds. It images the pricked spots 15 minutes after pricking, offering standardised and digital results for seamless record-keeping. Automating skin prick test accounts for a decrease in result variability and enable allergy testing efficiently. It is faster and requires less hands-on time or administration, reducing the workload for healthcare personnel and freeing up time for patient care. As allergy test results are digitally processed and stored, S.P.A.T. contributes to a more global, comprehensive understanding of allergies through deep scientific insights. Learn more about S.P.A.T. and what it would mean for your institution on www.hippo-dx.com
Location: Belgium, Flemish Region, Aarschot
Employees: 11-50
Founded date: 2020
Investors 1
| Date | Name | Website |
| 29.11.2023 | AllerFund | allerfund.... |
Mentions in press and media 1
| Date | Title | Description |
| 04.10.2023 | Belgium medtech Hippo Dx raises €4.4M for its fast, cheap, accurate allergy testing device | Read this article in: Belgium-based Hippo Dx, a MedTech startup that has developed an allergy testing device that is faster, cheaper, and more accurate, announced that it has secured €4.4M in a fresh round of funding to scale up internation... |